Sciensus | European life sciences organisation

Are you a patient?

Visit our Patient Hub for support, guidance, resources and more.

Access to patients in Europe
starts with us

With more than 30 years’ experience in navigating and unlocking the complex European healthcare ecosystem, we can help you accelerate your development journey, bringing products to market with direct access to patients and improving overall health outcomes.

Through our skilled team of 700 licensed clinical staff, we support over 240,000 patients and partner with over 3,000 pharmacies and hospitals each year – more than any other European partner.

With validated expertise and unparalleled patient access, we’ll help you ensure that your life-changing medicine gets to the right patients at the right time.

View our company overview

From understanding to impact

Our in-market expertise, based on real-world evidence and insights, is captured from over 150,000 patients through our innovative digital apps and platforms. This deep understanding of the patient experience is critical in helping our partners successfully navigate the complexities of the European market.

Patient access

Ensuring patients with cancer, chronic conditions and rare diseases can access life-changing medications when they need them most. Our unique patient reach opens opportunities for non-interventional and decentralised study participation, ensuring patients have access to the right products and optimal support programmes, which helps them stay on treatment longer.

Patient engagement

Empowering patients through cutting-edge patient engagement programmes , from clinical to commercial, we enable the collection and utilisation of real-world data to maximise your product’s value and impact. This deep understanding of the patient experience leads to improvements in adherence to treatment and better health outcomes.

Actionable insights

Harnessing the power of emerging digital capabilities and human support to provide real-world data that delivers clarity for critical decision-making. Skilled clinical staff, backed up by innovative digital support, connect stakeholders throughout the healthcare ecosystem to drive product value and improve patient outcomes.

Transforming insights into life-changing actions

Through more than 30 years of in-market expertise, evidence and insights, we’re unlocking the complex European market. We’ll help you accelerate your development journey and bring products directly to patients with expert patient care and digitally enhanced tools.

Cancer

We are Europe’s leading provider of at-home cancer care, providing systemic anti-cancer therapies for patients and personalised support through digital apps and personalised interventions.

Sciensus Digital+

Through advanced digital platforms and expert patient care, we leverage AI and machine learning to connect pharma to actionable insights about how patients interact with their medicine in real-world settings, positively transforming patient experiences.

Rare and orphan diseases

Our global network of experts and tailored end-to-end solutions are dedicated to helping biopharma get their rare and orphan medicines to hard-to-reach patients in Europe and beyond.

Long-term conditions

We meet the complex medical needs of over 240,000 patients each year across 50 therapy areas. Our best-in-class digital apps gather real-world patient insights that help clinicians and pharma make faster, better – data-driven – decisions.

Expertise that makes the difference

With our clinical expertise, experience and insights, no one knows patients like we do.

0

drugs distributed per year

0

patient interactions

0

patients supported each year

0

patients active on our apps

As a strategic partner, they have exceeded our expectations by finding global patients, who need our drugs, and enabling them to receive their life-extending medications.
Chief Commercial Officer at leading US Biotech company

News and Insights

Stay up to date with the news and learn from our experts across Sciensus.

News

Sciensus announces appointment of Kerry Utton as it continues to strengthen its pharma capabilities

Sciensus, a leading European life sciences organisation, focused on accelerating patients’ access to lifesaving medicines, is pleased to announce that…

Thought Leadership

Expand into Europe: unlocking the orphan drug market